Science Explorer Back to mapMap

Most cited papers in Diabetes, Cardiovascular Risks, and Lipoproteins

Diabetes, Cardiovascular Risks, and Lipoproteins

What are the most cited papers in Diabetes, Cardiovascular Risks, and Lipoproteins?

The most cited paper in Diabetes, Cardiovascular Risks, and Lipoproteins is "Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge" (William T. Friedewald, Robert I. Levy, Donald S. Fredrickson, 1972), with 32,670 citations. Next come "Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin" (19,192) and "Global Prevalence of Diabetes" (15,370).

Showing 50 of 98 papers. Every paper with more than 3,201 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge William T. Friedewald, Robert I. Levy, Donald S. Fredrickson · Clinical Chemistry Jun 1972 32,670
2 Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin Diabetes Prevention Program Research Group · New England Journal of Medicine Open access 7 Feb 2002 19,192
3 Global Prevalence of Diabetes Sarah H. Wild, Gojka Roglić, Anders Green et al. · Diabetes Care May 2004 15,370
4 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation K. G. M. M. Alberti, Paul Zimmet, WHO Consultation · Diabetic Medicine Jul 1998 15,336
5 Harmonizing the Metabolic Syndrome K. G. M. M. Alberti, Robert H. Eckel, Scott M. Grundy et al. · Circulation Open access 5 Oct 2009 14,957
6 International Diabetes Federation 2017 Ann M. Carracher, Payal H. Marathe, Kelly L. Close · Journal of Diabetes 18 Jan 2018 13,571
7 Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Salim Yusuf, Steven Hawken, Stephanie Ôunpuu et al. · The Lancet Open access Sep 2004 12,111
8 Diagnosis and Management of the Metabolic Syndrome Scott M. Grundy, James I. Cleeman, Stephen R. Daniels et al. · Circulation Open access 13 Sep 2005 11,924
9 Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes Zobair M. Younossi, Aaron B. Koenig, Dinan Abdelatif et al. · Hepatology 28 Dec 2015 11,032
10 Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance Jaakko O. Tuomilehto, Jaana Lindström, Johan Gunnar Eriksson et al. · New England Journal of Medicine Open access 3 May 2001 10,985
11 Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition Pouya Saeedi, Inga Petersohn, Paraskevi Salpea et al. · Diabetes Research and Clinical Practice 10 Sep 2019 10,771
12 IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 Hong Sun, Pouya Saeedi, Suvi Karuranga et al. · Diabetes Research and Clinical Practice Open access 5 Dec 2021 10,305
13 Prediction of Coronary Heart Disease Using Risk Factor Categories Peter W.F. Wilson, Ralph B. D’Agostino, Daniel Levy et al. · Circulation 12 May 1998 9,689
14 The metabolic syndrome—a new worldwide definition K. G. M. M. Alberti, Paul Zimmet, Jonathan Edward Shaw · The Lancet Sep 2005 9,351
15 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk François Mach et al. · European Heart Journal Open access154 authors 31 Aug 2019 9,175
16 Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study IRENE M. STRATTON · BMJ Open access 12 Aug 2000 9,131
17 THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM Richard J. Havel, Howard A. Eder, Joseph H. Bragdon · Journal of Clinical Investigation Open access Sep 1955 8,822
18 Standards of Medical Care in Diabetes David V. Power · Diabetes Care Feb 2006 8,690
19 Effects of Intensive Glucose Lowering in Type 2 Diabetes The Action to Control Cardiovascular Risk in Diabetes Study Group · New England Journal of Medicine Open access 6 Jun 2008 7,953
20 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes Rury R. Holman, Sanjoy Ketan Paul, Mary Angelyn Bethel et al. · New England Journal of Medicine Open access 10 Sep 2008 7,824
21 Global burden of hypertension: analysis of worldwide data Patricia M. Kearney, Megan Whelton, Kristi Reynolds et al. · The Lancet 2005 7,745
22 Prevalence and Trends in Obesity Among US Adults, 1999-2008 Katherine M. Flegal · JAMA 13 Jan 2010 7,642
23 IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045 N.H. Cho, Jonathan Edward Shaw, Suvi Karuranga et al. · Diabetes Research and Clinical Practice 26 Feb 2018 7,503
24 Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia James Banks Shepherd, Stuart M. Cobbe, Ian Ford et al. · New England Journal of Medicine Open access 16 Nov 1995 7,501
25 Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes The ADVANCE Collaborative Group · New England Journal of Medicine Open access 6 Jun 2008 7,469
26 Global estimates of the prevalence of diabetes for 2010 and 2030 Jonathan Edward Shaw, Richard A. Sicree, Paul Zimmet · Diabetes Research and Clinical Practice 7 Nov 2009 7,277
27 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults Neil J. Stone, Jennifer G. Robinson, Alice Hinda Lichtenstein et al. · Circulation 12 Nov 2013 7,118
28 IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040 Katherine Ogurtsova, João Diogo da Rocha Fernandes, Yadi Huang et al. · Diabetes Research and Clinical Practice 31 Mar 2017 7,101
29 Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines Scott M. Grundy, James I. Cleeman, C. Noel Bairey Merz et al. · Circulation Open access 12 Jul 2004 6,936
30 Prevalence of the Metabolic Syndrome Among US Adults Earl S. Ford, Wayne H. Giles, William H. Dietz · JAMA 16 Jan 2002 6,729
31 Heart Disease and Stroke Statistics—2016 Update Dariush Mozaffarian et al. · Circulation 16 Dec 2015 6,664
32 Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation K. G. M. M. Alberti, Paul Zimmet, Jonathan Edward Shaw · Diabetic Medicine Open access 20 Apr 2006 6,652
33 Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond Michael J. Pencina, Ralph B. D' Agostino, Ralph B. D' Agostino et al. · Statistics in Medicine Open access 13 Jun 2007 6,517
34 Beyond Cholesterol Franklin H. Epstein, Daniel I. Steinberg, Sampath Parthasarathy et al. · New England Journal of Medicine 6 Apr 1989 6,437
35 Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections Hilary O.M. King, Ronald E. Aubert, William H. Herman · Diabetes Care Sep 1998 6,345
36 The metabolic syndrome Robert H. Eckel, KGMM Alberti, Scott M. Grundy et al. · The Lancet 2010 6,328
37 Prevalence and Trends in Obesity Among US Adults, 1999-2000 Katherine M. Flegal · JAMA 9 Oct 2002 6,221
38 Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001 Ali H. Mokdad, Earl S. Ford, Barbara A. Bowman et al. · JAMA 2003 5,933
39 Global and societal implications of the diabetes epidemic Paul Zimmet, K. G. M. M. Alberti, Jonathan Edward Shaw · Nature Open access Dec 2001 5,915
40 Global aetiology and epidemiology of type 2 diabetes mellitus and its complications Yan Zheng, Sylvia H. Ley, Frank B. Hu · Nature Reviews Endocrinology Review 8 Dec 2017 5,865
41 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Masafumi Matsuda, Ralph A. DeFronzo · Diabetes Care Sep 1999 5,695
42 Oxidative Stress and Diabetic Complications Ferdinando Giacco, Michael Brownlee · Circulation Research Open access 28 Oct 2010 5,514
43 Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010 Katherine M. Flegal, Margaret Deutsch Carroll, Brian K. Kit et al. · JAMA 18 Jan 2012 5,424
44 Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Ronán Michael Conroy · European Heart Journal Jun 2003 5,360
45 Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants Mariachiara Di Cesare · The Lancet Open access Apr 2016 5,317
46 Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels John R. Downs, Michael B. Clearfield, Stephen E. Weis et al. · JAMA 27 May 1998 5,297
47 Heart Disease and Stroke Statistics—2014 Update Alan S. Go et al. · Circulation Open access 18 Dec 2013 5,239
48 Heart Disease and Stroke Statistics—2013 Update Alan S. Go et al. · Circulation Open access 13 Dec 2012 5,194
49 The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men Hanna‐Maaria Lakka · JAMA 4 Dec 2002 5,080
50 Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes Christopher Paul Cannon, Eugene Braunwald, Carolyn H. McCabe et al. · New England Journal of Medicine Open access 7 Apr 2004 4,973

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.